Pharmacodynamics and dosing of aminoglycosides

J Turnidge - Infectious Disease Clinics, 2003 - id.theclinics.com
Despite their toxicity, aminoglycosides continue to play a pivotal role in the management of
serious infections. Indeed, their toxicity has led to comparatively restrained usage, and as a …

Facilitation of drug evaluation in children by population methods and modelling

M Tod, V Jullien, G Pons - Clinical pharmacokinetics, 2008 - Springer
The pharmacokinetics and pharmacodynamics of drugs are different in adult and paediatric
populations, the latter being particularly heterogeneous. These differences in …

A mechanistic approach for the scaling of clearance in children

AN Edginton, W Schmitt, B Voith, S Willmann - Clinical pharmacokinetics, 2006 - Springer
Background and objective Clearance is an important pharmacokinetic concept for scaling
dosage, understanding the risks of drug-drug interactions and environmental risk …

Scaling clearance in paediatric pharmacokinetics: all models are wrong, which are useful?

E Germovsek, CIS Barker, M Sharland… - British journal of …, 2017 - Wiley Online Library
Linked Articles This article is commented on in the editorial by Holford NHG and Anderson
BJ. Why standards are useful for predicting doses. Br J Clin Pharmacol 2017; 83: 685–7. doi …

Ontogeny of hepatic and renal systemic clearance pathways in infants: part II

J Alcorn, PJ McNamara - Clinical pharmacokinetics, 2002 - Springer
Maturation of drug systemic clearance mechanisms during the postnatal period produces
dramatic and rapid changes in an infant's capacity to eliminate drugs. A tentative general …

Therapeutic drug monitoring of aminoglycosides in neonates

DJ Touw, EM Westerman, AJ Sprij - Clinical pharmacokinetics, 2009 - Springer
The efficacy and toxicity of aminoglycosides show a strong direct positive relationship with
blood drug concentrations, therefore, therapy with aminoglycosides in adults is usually …

Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates

M Wilbaux, A Fuchs, J Samardzic… - The Journal of …, 2016 - Wiley Online Library
Sepsis remains a major cause of mortality and morbidity in neonates, and, as a
consequence, antibiotics are the most frequently prescribed drugs in this vulnerable patient …

Clinical pharmacokinetics of aminoglycosides in the neonate: a review

GM Pacifici - European journal of clinical pharmacology, 2009 - Springer
Background Sepsis is common in neonates and is a major cause of morbidity and mortality.
Sixty percent of preterm neonates receive at least one antibiotic, and 43% of the antibiotics …

Parenteral antibiotics for the treatment of serious neonatal bacterial infections in developing country settings

GL Darmstadt, M Batra, AKM Zaidi - The Pediatric infectious …, 2009 - journals.lww.com
Background: A number of special issues must be considered when selecting simple, safe,
inexpensive, and effective antimicrobial regimens for treatment of neonatal sepsis in …

Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy

CC Llanos-Paez, S Hennig… - Journal of Antimicrobial …, 2017 - academic.oup.com
Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic
pharmacodynamic modelling are all tools that can be applied to personalize gentamicin …